RP
Rebecca Silberman, Ph.D.
Investment Director·RA Capital Management
Rebecca Silberman is an Investment Director on RA Capital's Venture Team, where she identifies opportunities for new company creation and early-stage investments and advises portfolio companies. Conference bios have described her as a board observer for portfolio companies including Triana Biomedicines, Ambagon Therapeutics, and Ventus Therapeutics. She holds biology degrees from Colgate University and MIT.
See the rest of Rebecca Silberman, Ph.D.'s profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.